What question did this study set out to answer?

The aim is to identify factors associated with chronic immune thrombocytopenia and evaluate treatment patterns in children.

June 15, 2026Frontiers in PediatricsOpen Access

Fifteen years of pediatric immune thrombocytopenia in a national cohort: chronicity, diagnostic challenges, and treatment patterns—single center experience

View Full Paper

Ask AI

Bookmark

Authors

KPKatja PregeljcUniversity of Ljubljana EFElena FavarettoCa' Foncello Hospital FVFederico VerzegnassiIRCCS Materno Infantile Burlo Garofolo

Discussion

Member takes

Implication

Retrospective study evaluates diagnostic challenges and treatment patterns for chronic immune thrombocytopenia in children, suggesting clinical insights for management.

Key Points

The aim is to identify factors associated with chronic immune thrombocytopenia and evaluate treatment patterns in children.
Retrospective single-center study with 271 patients aged ≤18 years evaluated for immune thrombocytopenia from 2009 to 2024.
Demographic, clinical, laboratory, and therapeutic data were collected at diagnosis and follow-up.
Logistic regression assessed factors related to chronic disease with odds ratios and Kaplan–Meier analysis described bleeding complications.
Chronic immune thrombocytopenia was associated with older age (OR 1.08; p = 0.017) and higher platelet count at diagnosis (OR 1.03, p < 0.0001).
Patients receiving pharmacological therapy had higher bleeding grades and lower platelet counts compared to those managed with observation.
Bleeding complications were more frequent in the pharmacological therapy group, while the watch-and-wait group had more severe cases.

Cite This Study

Pregeljc et al. (2026) studied this question.

synapsesocial.com/papers/6a2f95b4a1cfeec4908279b7 https://doi.org/10.3389/fped.2026.1864433

View Full Paper

Ask AI

Bookmark

Implication

Retrospective study evaluates diagnostic challenges and treatment patterns for chronic immune thrombocytopenia in children, suggesting clinical insights for management.

Fifteen years of pediatric immune thrombocytopenia in a national cohort: chronicity, diagnostic challenges, and treatment patterns—single center experience

Discussion

Member takes

Implication

Key Points

Cite This Study

Fifteen years of pediatric immune thrombocytopenia in a national cohort: chronicity, diagnostic challenges, and treatment patterns—single center experience

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider